Press Releases

Read Regulatory and non-regulatory press releases

  • All
  • Non-Regulatory
  • Regulatory
Regulatory

Oncology Venture has established bridge loan facility

Regulatory

NOTICE TO CONVENE ORDINARY GENERAL MEETING

Regulatory

Oncology Venture publishes the Annual Report for 2018

Regulatory

Oncology Venture receives guarantees and undertakings for a proposed rights issue

Regulatory

Oncology Venture rearranges its financing agreement with EHGOS (Alpha Blue Ocean)

Regulatory

First patient dosed in a Phase 2 study with LiPlaCis in prostate cancer

Regulatory

Clinical update: Dovitinib DRP data mining successfully completed and new LiPlaCis data continues to support an FDA breakthrough designation strategy

Regulatory

Communique from EGM in Oncology Venture A/S

Regulatory

Oncology Venture receives positive feed-back from the FDA on approval pathway for LiPlaCis and DRP in the US

Regulatory

Oncology Ventures CEO Peter Buhl Jensen buys shares in the Company

Regulatory

Claus Frisenberg Pedersen, CCO in Oncology Venture buys shares in the Company

Regulatory

Claus Frisenberg Pedersen, CCO in Oncology Venture buys shares in the Company

Regulatory

Peter Buhl Jensen, CEO in Oncology Venture buys shares in the Company

Regulatory

Correction new weekday: Oncology Venture: Notice to Convene Extraordinary General Meeting

Regulatory

Oncology Venture: Notice to Convene Extraordinary General Meeting

Regulatory

Oncology Venture A/S: Publication of financial report Q3 2018

Regulatory

Oncology Venture enters into financing agreement

Non-Regulatory

OV – Update Regarding Participation at Investor Events in Q4 2018

Regulatory

OV – Clinical up-date

Regulatory

OV – OV increases its share capital due to warrant exercise